News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Veradermics Closes Series B Financing and Initiates Phase 2/3 Trial for Hair Loss
Veradermics is a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions.
Vivodyne Weighs in on FDA Proposed Initiative
The FDA recently revealed a new initiative aimed at eliminating the need to test antibody therapeutics in animal models and replacing them with AI modelling or lab-grown human organoids.
Opus Genetics Celebrates Early Win for Retinal Gene Therapy in Pediatric Patient
According to the data, the 16-year-old patient, who was treated in February, showed "meaningful improvement in visual function."
Philadelphia Launches SBIR/STTR Matching Grant Program
Philadelphia has launched a new matching grant program to support local life sciences companies.
Greater Philadelphia Maintains #4 U.S. Life Sciences Market Rank in Colliers 2025 Report
The report recognizes the region’s strong VC funding environment, robust life sciences talent pool and growing life sciences real estate leasing activity.
Penn Researchers Help Develop Data-driven Map Showing Local Economic Impact of Cuts to Federal Funding for Health Research
The Science & Community Impacts Mapping Project (SCIMaP) aims to demonstrate how reduced investment in health research negatively affects both innovation and local economies.
Penn Medicine’s Kiran Musunuru Featured in The New York Times for Gene Therapy Breakthrough
Musunuru explained that this method offers the hope of treating other genetic diseases by fixing mutations .
Penn I-Corps Spring 2025 Cohort
Read a detailed list of the teams from the Penn I-Corps Spring 2025 cohort.
Meet the Fellows Alumni
Learn about past cohorts from the PCI Fellows program.
Meet the 2025/2026 PCI Fellows Cohort
Eleven fellows were admitted to the 2023/2024 cohort out of a large application pool.